FDA Cites Minneapolis Compounding Pharmacy Over Sanitation Issues

Drug Industry Daily
A A
Minneapolis, Minnesota-based Fairview Compounding Pharmacy was hit with a Form 483 after an FDA inspection in April revealed serious sterilization deficiencies.

To View This Article:

Login

Subscribe To Drug Industry Daily